OBJECTIVE: To determine whether the oral administration of oleoyl-estrone has similar mass-decreasing effects on the main different sites of white adipose tissue (WAT). DESIGN: Adult male Zucker lean rats were given a daily oral gavage of oleoyl-estrone (OE, 10 mmol=kg) in 0.2 ml of sunflower oil for 10 days, and were compared with controls receiving only the oil. The mass of the main WAT sites: subcutaneous, epididymal, mesenteric, retroperitoneal, gluteal, perirenal and interscapular, as well as perirenal and interscapular brown adipose tissue (BAT), were dissected and studied. MEASUREMENTS: The tissue weight, DNA, protein, lipid and total cholesterol content, together with the levels of leptin and acyl-estrone in the larger WAT and BAT masses, were measured. RESULTS: The weights of WAT depots were correlated with body weight but those of BAT were not. Cell size was maximal for epididymal and mesenteric and minimal for subcutaneous and retroperitoneal WAT and BAT. Differences were detected in DNA, and in protein and lipid content between distinct WAT sites. OE treatment tended to decrease cell number and cell size in WAT; only small differences in composition were found between WAT locations inside the visceral cavity and those outside. Decreases in lipid content were maximal in mesenteric fat. Leptin and acyl-estrone content were fairly uniform at the different WAT sites, except for high concentrations in gluteal WAT. OE induced a greater decrease in leptin and acyl-estrone than in DNA and lipids; changes in these hormones were fairly parallel in all sites. CONCLUSIONS: In general, the differences in composition between visceral and peripheral subcutaneous WAT and their responses to OE were less marked than the individual differences observed between specific sites, regardless of location. WAT sites are fairly diverse in composition, but their response to OE treatment was uniform. OE decreased the weight of WAT through reduction of both cell numbers and size; but did not change the mass or composition of BAT significantly. The effects of OE are more marked in the hormonal signals (leptin and acyl-estrone) from the tissue than in its composition and mass.
Introduction
White adipose tissue (WAT) has long been considered the site for energy storage in the form of fat. However, its dynamic role in energy metabolism is now fully recognized, mainly as a consequence of the uncovering of the role of brown adipose tissue (BAT) in thermogenesis 1 and the finding of leptin and other endocrine roles for WAT. 2, 3 Another widely maintained paradigm of adipose tissue is its uniformity. In spite of the well-known metabolic differences between subcutaneous and visceral fat, 4 the tendency to assume histological, physiological and biochemical uniformity of this tissue continues. Nevertheless, all adipose tissue in a given organism can be considered a distinct organ, the adipose organ, whose primary function is energy storage and handling. 5 WAT is distributed in a number of large depots and other smaller masses, the latter occupying spaces in between other organs and tissues. In addition, fat is stored in other organs and tissues, such as muscle (both as intracellular fat droplets and as interstitial WAT) and liver. The histological properties of WAT in these locations are slightly different, as is their cell size. 6, 7 Most biochemical, genetic and endocrine studies rely on the study of a specific WAT site, the choice of which is conditioned mainly by accessibility, uniformity and sufficient mass. The most selected sites for these studies are epididymal or periovaric fat pads, inguinal subcutaneous fat and the retroperitoneal (or lumbar) cordons and perirenal depots. Other locations yield lower amounts of WAT, which often include small amounts of BAT and=or other tissues (ie conjunctive or muscular). The data obtained from these locations is commonly extrapolated to all WAT.
The control of fat mass is essentially regulated by signals mainly from the brain, but also from WAT. Leptin, a cytokine produced by WAT, plays a key role in the response to starvation. 8 In non-obese individuals, levels of this cytokine in plasma are related to fat mass, 9 and they change sharply with food deprivation and other energy manipulations. 10 Similarly, oleoyl-estrone (OE) is synthesized by WAT, and in non-obese subjects its levels are directly related to body fat. 11 However, OE concentration is less affected by starvation than leptin. 12 Treatment with OE results in the loss of body fat, sparing protein 13 by decreasing food intake and maintaining energy expenditure. 14 Here we have examined the diversity of several parameters of tissue composition in a number of WAT and BAT locations in normal male rats. We have added a 10-day standard OE treatment, a powerful slimming agent, to ascertain whether the responses of these selected sites are uniform. In addition, we have determined the extent of the leptin and acyl-estrone response to OE. Oleoyl-estrone and adipose tissue composition X Remesar et al
Methods
Fifteen-week old male Zucker lean rats (265 -345 g) were used. The animals were housed and fed under standard conditions. Two groups of animals were randomly selected, controls (n ¼ 7) and OE-treated (n ¼ 6). The latter received a daily oral gavage of 0.2 ml sunflower oil containing oleoylestrone, which resulted in a daily dose of 10 mmol=kg. Controls received oil alone. The oral treatment was continued for 10 days.
On day 10, the rats were killed by decapitation and blood was collected in dry heparinized beakers. It was then immediately centrifuged at 4 C and the plasma was frozen and kept at 7 30 C until analysis. The bodies were then dissected, and pieces of liver and the striated muscle of hind leg were obtained. Rats were then skinned, and the main adipose tissue masses (WAT and BAT) were carefully dissected, weighed, frozen and stored for further analyses; adipose tissue adhering to the pelt was also dissected. The samples obtained from the adipose sites are shown in Figure 1 in the order in which they were taken: mesenteric, epididymal, retroperitoneal cordons, perirenal (separating WAT from BAT masses around the kidneys and lower aorta, which were also sampled), gluteal, interscapular (BAT and the small surrounding portions of WAT). Finally, the subcutaneous WAT bound to the muscles or to the inside of the pelt was also weighed and sampled. Thorough dissection ensured that no macroscopic WAT or BAT (the latter only in perirenal and interscapular areas) remained attached to the carcass or skin. The head was not included in the analysis, nor was the fat present in the mediastinic space, intermuscular fat, or that dispersed in other tissues, including that infiltrating skin and connective tissue.
Samples of adipose tissue were used to determine total protein content following the Lowry method. 15 DNA content was measured by a standard fluorometric method 16 with 3,5-diaminobenzoic acid (Sigma, St Charles, MO, USA), using bovine thymus DNA as standard (Sigma). Lipids were extracted with trichloromethane=methanol (3:1); 17 total lipids were measured gravimetrically. 17 Muscle and liver total lipids were determined using the same method. The lipid extract was also used to measure total cholesterol content using an enzymatic method 18 (Cholesterol HF B7576; Menarini, Milano, Italy).
Tissue samples were homogenized in buffer 19 using a cell disruptor (Politron, Kinematica, Luzern, Switzerland). After centrifugation, the clear supernatants (free of the fat layer) and plasma samples were used to estimate leptin by radioimmunoassay (rat leptin kit RL-83LX; Linco, St Charles, MO, USA). Lipid trichloromethane=methanol extracts of adipose tissue samples and plasma were also used to analyse acyl-estrone content after saponification and to measure the free estrone evolved, by means of radioimmunoassay. 20 Because of insufficient sample, tissue composition studies were done only on mesenteric, epididymal, retroperitoneal, subcutaneous and gluteal WAT and on interscapular BAT.
Since all cell nuclei contain the same amount of DNA, about 6 mg DNA per million cells, 21 we were able to determine the approximate number of cells in a given WAT site by dividing its DNA content by the mean DNA content of a cell (6 pg=cell). The mean mass of the cells in a given WAT site was determined dividing the weight of WAT by the number of cells it contained. Figure 2 presents the relative mass of WAT in the locations as a percentage of body weight at the end of the 10-day study. Subcutaneous fat accounted for more than half of the total WAT mass. OE treatment decreased the percentage of body WAT in all locations, but mesenteric tissue was more affected than subcutaneous and epididymal fat depots. In OE-treated rats, the differences in BAT mass were small compared with controls, with little change attributable to OE.
Results
The weights of adipose tissue from each site in controls were plotted against their body weights. There was a linear correlation between the mass of WAT in each location and rat weight; in all cases, the corresponding linear regression values were in the range 0.82 -0.95 (Table 1 ). This linear relationship was not observed in the two BAT sites tested. Since the control rats grew a mean 3 AE 1% in the 10 days of Figure 2 Relative mass of WAT in the locations studied, showing the overall effect of oleoyl-estrone. Data are the mean AE s.e.m. of seven (controls) or six (OE group) rats. Statistical significance of the differences between groups (ANOVA): variable 'OE-treatment' P ¼ 0.0086.
Oleoyl-estrone and adipose tissue composition X Remesar et al the study, direct comparison with treated rats was not immediate. OE treatment resulted in a net loss of body weight of 6 AE 2%. The decrease in WAT mass, however, was greater a mean of 27% (Table 1 ). The highest relative loss of mass was observed in the mesenteric and retroperitoneal locations. BAT mass did not change, bringing its relationship to body weight to 0.29 AE 0.01%, a slightly higher figure than that of controls (0.26 AE 0.02%; differences not significant).
In controls, DNA content per unit of tissue weight (Table  2 ) differed greatly by a factor of 2.5 between subcutaneous and epididymal fat depots, suggesting different cell sizes in the WAT locations studied. The highest cellularity (smaller cells) would then correspond to subcutaneous WAT, followed in increasing cell size by retroperitoneal, gluteal, mesenteric and epididymal depots. Table 1 also shows the approximate cell sizes calculated for the main adipose tissue locations tested. Epididymal cells were roughly six-fold larger than BAT cells, and about twice the size of those located subcutaneously. OE treatment tended to diminish the mass of individual cells, but to a lower extent than the decrease observed for tissue weight. There was a significant loss of WAT mass overall, but neither the number of cells at the tissue locations nor their mean size were significantly different from controls despite being systematically lower in all locations, which suggests that probably a net cell loss coupled with cell size decrease were responsible for the overall loss of tissue mass observed in different WAT locations.
The changes in the protein content of adipose tissue are shown in Table 3 . The ratios of protein to WAT mass differed greatly between locations, ranging from 0.6 to 2.5% in epididymal and mesenteric cells. This distribution agrees with the different cellularity of WAT at the distinct locations. Rat body weights: controls 294 AE 9 g (day 0) and 302 AE 13 g (day 10) (increased 9 AE 4 g, 3AE 1% of initial body weight); OE-treated 307 AE 7 g (day 0) and 289 AE 12 g (day 10) (increased 718 AE 6 g, 76 AE 2% of initial body weight). Statistical analysis of the differences (WAT) between OE and controls (two-way ANOVA): weight P ¼ 0.014; number of cells P ¼ 0.585; cell mass P ¼ 0.271). Oleoyl-estrone and adipose tissue composition X Remesar et al OE treatment produced more changes in protein content at the different sites than in DNA content. These changes ranged from the loss of half the protein content of mesenteric WAT to no changes in that of subcutaneous and gluteal cells. Nevertheless, the overall change in WAT protein content was similar to that observed for DNA (715% for protein vs 711% for DNA). BAT protein was again practically unchanged.
The concentration of lipids in WAT locations was highest in epididymal and lowest in subcutaneous and mesenteric tissue (Table 4 ). This pattern closely follows an inverse relationship with the DNA and protein content, which confirms that the larger cells contained proportionally more lipids than the smaller ones. OE treatment induced a loss of fat tissue which was more uniform in all locations than the changes observed for DNA and protein. In all, WAT lost 29% of its lipids during OE treatment. Again, no changes were observed in BAT. Total lipid content in the muscles of controls and OE-treated rats was remarkably similar (1.25 AE 0.34 vs 1.25 AE 0.41% of tissue mass, respectively). Likewise, no change was detected in the lipid content of liver (2.51 AE 0.20 and 2.53 AE 0.38% in controls and OE-treated rats, respectively).
The cholesterol content of WAT ranged from 18 mmol=kg in subcutaneous tissue to 51 mmol=kg in gluteal cells (Table 5) Oleoyl-estrone and adipose tissue composition X Remesar et al Plasma leptin levels were 216 AE 51 pM in controls and 92 AE 13 pM in OE-treated rats. Acyl-estrone levels in plasma were 110 AE 6 nM and 136 AE 15 in controls and OE-treated animals, respectively. Table 6 shows the WAT leptin content of controls and OE-treated rats. Using the method described, leptin levels in BAT were too low to be reliable, and therefore are not shown. Since the amount of blood trapped in WAT is less than 2%, 22 the final contribution of plasma to tissue leptin levels is less than 1%. In controls, there was a range of about Â3 between mesenteric WAT, the tissue with lower leptin content, and gluteal WAT. OE treatment resulted in a generalized decrease in leptin levels. Figure 3 shows the ratios of leptin to lipid content in the WAT locations studied. There was considerable uniformity in this ratio for most sites, except for gluteal WAT, which showed much higher values. OE treatment tended to lower and uniform the ratio values, but the high gluteal leptin=lipid ratio was maintained.
The levels of acyl-estrone in adipose tissue ( Table 7 ) followed a distribution pattern similar to that of leptin, with highest values for gluteal WAT. As for leptin, the final contribution of acyl-estrone in trapped plasma was lower than 3% of the data given. OE treatment resulted in marked decreases in the total estrone content of WAT and, to a lower extent, in BAT. These decreases were similar to those observed for leptin. The pattern of change of the acylestrone=lipid ratios ( Figure 3 ) were similar to that of the leptin=lipid ratios: OE treatment decreased the ratio and tended to make the values more uniform, except in gluteal WAT, which showed high ratios. Figure 4 shows the absolute content of DNA, protein, lipid, cholesterol, leptin and acyl-estrone in the main WAT sites of controls and OE-treated rats. The maximal change is again observed in leptin and acyl-estrone content, followed by a considerable decrease in total lipids, and then to a lower extent by cholesterol and protein, with minimal changes in DNA content. When the content of protein, lipid, cholesterol, leptin and acyl-estrone were calculated per unit of tissue DNA, the differences, observed when compared on a weight basis, between OE-treated and control rats practically disappeared. The only significant (P < 0.05) decreases were found for epididymal, gluteal, and total WAT leptin; no Oleoyl-estrone and adipose tissue composition X Remesar et al statistically significant differences were observed between OE and control rats for all other parameters and sites. No differences either were found when the leptin data were compared on a protein content basis, except for a significant decrease in the composite total WAT figure. The lack of changes on a DNA basis suggests that at least part of the effects observed in OE-treated rats are a consequence of decreased cell content. Data for the sites were grouped into two main categories according to their location with respect to the muscle layer: 'internal' (mesenteric, retroperitoneal and perirenal) vs 'peripheral' (subcutaneous, epididymal, interscapular and gluteal). Control data reflected the increase in body weight, which was assumed affected lineally all the parameters studied. OE-treated rats tended to show more marked changes in internal than external sites. This was most apparent for protein, but also for tissue weight, lipid and cholesterol content, with no differences in DNA. Although leptin and acyl-estrone changed more dramatically in the external sites, the differences were nevertheless small.
Discussion
The adipose tissue locations showed a wide variation in cell size and lipid content; the proportions of cholesterol to total lipid also compound these differences. These data are consistent with previous studies 7, 23 and highlight the lack of structural, biochemical and functional 24, 25 uniformity in WAT sites.
The total amount of WAT (and BAT) recovered from the dissection showed a lower amount of adipose tissue than that expected from the lipid content of similar groups of animals, ie about 8% of body weight as lipid. 13 The lipid content of the tissue recovered, including liver and muscle lipid, did not account for even half of total body lipids, which suggests that in male Zucker lean rats a very large part of these lipids is dispersed in other locations, probably as infiltrated WAT in other tissues. In larger Wistar male rats, the mass of the adipose tissue recovered accounted for a higher percentage of body weight than that found here, 26 which suggests that strain and size may also be critical factors in the distribution and overall mass of WAT.
There was a significat direct correlation between WAT mass in each location with respect to body size, a correlation not found for BAT, which suggests that WAT mass grows more harmonically than BAT as a correlate of size, whereas BAT mass is less a consequence of size but of thermogenic needs.
WAT diversity was even more apparent when the tissue composition was studied. The changes in lipid content closely followed those in tissue mass, since this is the parameter that showed the most quantitative change. Overall changes in DNA and protein content were similar, but differences between locations were, in some cases, extreme. In spite of the widely held assumption that visceral (ie mesenteric, but also retroperitoneal and perirenal) fat has a distinct metabolic function to subcutaneous fat depots, 27 the data on composition and the changes induced by OE treatment do not fully support this assumption. The differences in internal and external fat depots were small, and the only clear differences were found for protein, perhaps because of a higher extraction of conjunctive tissue in dissection of rat Figure 3 Leptin=and acyl-estrone=lipid ratios in WAT locations of control and OE-treated rats. Upper panel: leptin=lipid ratio; lower panel: acyl-estrone=lipid ratio. Open bars ¼ controls; shaded bars ¼ OE-treated. The data are the mean AE s.e.m. of seven (controls) or six (OE group) rats. The horizontal dotted line represents the mean value for all WAT locations, corrected by their relative masses of control rats. The continuous horizontal line represents the corresponding mean for treated animals. Statistical significance of the differences between groups (ANOVA) -variable 'OE-treatment' leptin, P ¼ 0.0251; OE, P ¼ 0.1013, variable 'location' leptin, P ¼ 0.0001, acyl-estrone, P ¼ 0.0059 (post-hoc Duncan test, different small case letters indicate a significant (P < 0.05) difference between locations). When leptin and acyl-estrone data are rendered uniform by arbitrarily giving a value 100 to the mean for controls (dotted lines), a combined three-way ANOVA analysis of the data gave the global values: variable 'OE-treatment', P ¼ 0.0061; variable 'location', P ¼ 0.0000; variable 'leptin or acyl-estrone', P ¼ 0.4593.
Oleoyl-estrone and adipose tissue composition X Remesar et al pelts in the thinner OE-treated group. There was a lower external fat response to OE with respect to loss of mass, protein, lipid and cholesterol content, and a trend to reverse this pattern for leptin and acyl-estrone. The observation of a lack of changes in the lipid content of muscle and liver is consistent with previous studies, 28 and can be explained by higher lipid oxidation in muscle and increased plasma transport of lipids 29 observed in rats treated with oral OE. The overall lack of effects of OE on BAT mass and composition agree with the maintenance of energy expenditure (and thus of thermogenesis) elicited by OE treatment.
14 OE treatment reduces cholesterol content in all WAT locations, in a proportion similar (albeit somewhat smaller) to that of total lipid content. This may be related to increased plasma lipoprotein turnover and enhanced lipid transport of OE-treated rats. 29 The relative increase in the cholesterol level of BAT may be a secondary consequence of this increased lipoprotein cholesterol inter-organ (and excretion) transport.
Tissue concentrations of leptin were fairly uniform except for higher gluteal and epididymal levels; the distinct leptin secretion capability of visceral and subcutaneous WAT 30 were not fully observed here, since differences in levels in mesenteric (ie archetypical visceral fat) and subcutaneous fat were minimal. The higher levels of this hormone in the epididymal depots may bear some relationship with the role of leptin in the control of gonadotropin secretion 31 and the development and maintenance of sexual readiness. 32 The decreases in the leptin content of WAT elicited by OE are a consequence of the lower expression of the lep gene, 28 and affect all tissue locations.
The content of acyl-estrone in the different WAT locations is fairly uniform except for gluteal depots, which -as in leptin -show much higher values. This may be due in part to different rates of synthesis of these hormones or also to different vascularization of the tissue that resulted in different rates of effective removal of acyl-estrone and leptin from the cells.
OE treatment did not result, as could be expected, in an increase in total estrone in tissues: the daily gavage was, in all, more than 3500 times larger than the combined amount of acyl-estrone present in all the locations of WAT studied. The marked reduction in acyl-estrone content suggests that most of the OE in the gavage was rapidly excreted. The decrease in acyl-estrone was similar to that observed for leptin. This parallelism is even more evident when the acyl-estrone=lipid ratios are considered. There is a generalized decrease in both cases, which implies that the loss of either leptin or acyl-estrone is greater than that of fat. As a result, to compensate for the recent and rapid loss of fat, fat mass-related signals are produced in lower proportion. This response is typical of any feedback system, and enhances signalling function. However, these marked parallelisms and their known metabolic and control relationships 28, 33 suggest that leptin and oleoyl-estrone participation in the mechanisms controlling body fat mass are either complementary or sequential.
In general, the differences in composition between visceral and peripheral subcutaneous masses of WAT and their responses to OE were less marked than the individual differences observed between specific sites, regardless of their location. Our results suggest that the widely accepted division between 'visceral' and 'subcutaneous' or 'peripheral' fat does not fully correspond to two well-differentiated entities. The differences -at least in composition -between the WAT locations tend to be even greater than those observed between the combined 'internal' and 'external' pools.
The limited changes in mean cell size as well as in the number of cells in WAT locations suggest that the loss of WAT mass under treatment with OE is probably a combination of a decrease in the number of cells as well as a decrease in their mean size. Since most of the WAT cells are adipocytes we can safely assume that oral OE provokes the loss of cells in addition to decreased cell size, 23 the extent of this action, however, could not be fully determined because we do not know the direction or extent of the changes in other cell Oleoyl-estrone and adipose tissue composition X Remesar et al types present in WAT. In any case, the data presented show that the loss of tissue mass could not be explained by a decrease in cell size alone, but also by a diminution of the DNA content, ie the number of cells. This points to a possible apoptotic effect of OE; however, more data are needed to determine whether OE indeed acts through the elimination of adipocytes.
In conclusion, WAT sites are fairly diverse in composition; however, their response to OE treatment is more uniform. In addition to a marked loss of lipid, OE tends to decrease the Figure 4 Absolute content of DNA, protein, lipid, cholesterol, leptin and acyl-estrone in the main WAT sites studied of control and OE-treated rats. Data were taken from Tables 1 -6; they are the mean AE s.e.m. of seven (controls) or six (OE group) rats.
Oleoyl-estrone and adipose tissue composition X Remesar et al number of WAT cells and their size, but does not change the mass or composition of BAT significantly. The effects of OE are more marked on the hormonal signals from WAT, leptin and acyl-estrone than on its composition and mass.
